Ultrasound-Guided Injection

Ultrasound-guided injection begins before the needle is picked up. The clinician scans the area first to assess the target and to support or refine the diagnosis, to identify the vessels and nerves that lie on possible needle paths, using colour Doppler where vascular structures are a concern, and to plan an approach that avoids them. Transducer choice follows depth: a high-frequency linear transducer gives excellent resolution for superficial targets such as the subacromial-subdeltoid bursa, a tendon sheath or the common extensor origin, whereas a lower-frequency transducer with adequate penetration is needed to reach deeper targets such as the hip joint or a deep gluteal structure, commonly curvilinear but sometimes a lower-frequency linear probe, depending on habitus and the equipment available. The skin is prepared aseptically, sterile gel is used, and a probe cover maintains the sterile field.

Two needle approaches are used, and knowing the difference is examinable. In an in-plane approach the needle is advanced along the long axis of the transducer, within the plane of the ultrasound beam, so the shaft and the tip can be visualised as long as the needle remains within the beam; this facilitates continuous needle visualisation, particularly where precise tip control matters, such as near a nerve or vessel. In an out-of-plane approach the needle crosses the beam at right angles and appears only as a bright dot in cross-section, which carries the important pitfall that the bright dot may represent the shaft rather than the tip, so the tip can be deeper than the operator believes. Neither approach is universally preferable: the choice depends on the anatomy, a safe trajectory to the target, operator expertise and the ability to track the tip. The governing principle either way is to keep the tip in view, advance only when it is visible, and confirm placement by watching the injectate spread into the intended compartment rather than pooling in adjacent tissue, since seeing the fluid distribute correctly is the real confirmation that the target was reached.

The evidence separates cleanly into two questions that are often conflated. On accuracy, ultrasound guidance is consistently better than landmark or palpation-guided injection across a range of targets, with the improvement most convincing at the shoulder, knee, hip and small joints of the wrist and hand; blind injection into some targets misses more often than clinicians expect, and the miss rate is higher for deeper and smaller structures. On clinical outcome, the picture is much less settled. Whether greater accuracy delivers better pain and function scores has not been consistently demonstrated, an earlier systematic review of corticosteroid injection for shoulder pain found no clear overall benefit from ultrasound guidance, and later reviews report mixed results, with some showing modest improvements in procedural pain and short-term symptoms and others showing no meaningful difference. The reasonable summary for an exam is that ultrasound reliably improves where the needle goes, and may improve what the patient feels, but the second claim is weaker than the first.

That distinction shapes sensible practice rather than undermining the technique. Ultrasound guidance is most clearly justified where accuracy genuinely determines whether the treatment can work at all, such as a deep or small target, a structure adjacent to a nerve or vessel, a joint that is difficult to access, a patient in whom landmarks are hard to palpate, or a diagnostic block where an inaccurate injection would produce a misleading result. It is also valuable where the injectate must reach a specific compartment, such as a tendon sheath rather than the tendon itself, and where a previous landmark injection has failed and inaccurate placement is a plausible explanation. Conversely, a large easily palpable effusion or a familiar landmark injection that the clinician performs reliably does not require imaging, and the additional cost, time and equipment are not automatically justified. Ultrasound also brings genuine incidental advantages: it involves no ionising radiation, it allows dynamic assessment, and it lets the operator aspirate a joint and confirm that the effusion has been decompressed.

Ultrasound guidance is safe but it introduces its own requirements. The most important is competence: image-guided injection is a learned skill combining scanning, needle handling and interpretation, and a clinician performing it should be trained, supervised during acquisition of the skill, and practising within their competence, with the equipment maintained and the images and findings documented. Both techniques are operator-dependent, and ultrasound additionally requires competent image acquisition, interpretation and needle visualisation, so an inexperienced operator can produce a confident but wrong interpretation, and the belief that the injection was guided can create false reassurance. Infection prevention is unchanged in principle but has an extra component, since the transducer and gel are additional potential sources of contamination. The probe, the gel and the needle are managed according to the infection risk of the procedure and local policy: several arrangements are acceptable for low-risk procedures, while higher-risk procedures call for greater sterility, including a sterile probe cover and sterile gel. The transducer is decontaminated between patients according to local policy, and the aseptic non-touch principle continues to apply.

Documentation and consent follow the same standards as any injection, with the addition of what the scan showed. A good record notes the indication, the relevant scan findings, the target, the approach used, the needle and the agent and dose, that the tip was visualised, how the injectate spread, and any immediate complication. Practical pitfalls are worth knowing. Needle visualisation degrades as the angle of insertion becomes steeper relative to the beam, so a needle angle that is less steep relative to the skin, and more favourable relative to the beam, improves the image; heel-toe manipulation of the transducer and beam-steering functions can help. Anisotropy, the apparent change in tendon echogenicity when the beam is not perpendicular, can mimic a tear and is corrected by adjusting the probe angle. Air introduced during injection scatters the beam and obscures the view, so the syringe and tubing are purged first. Finally, ultrasound does not remove the need for anatomical knowledge; it makes anatomical knowledge visible, and an operator who cannot name the structures on the screen is not being made safer by the machine.

• •Ultrasound guidance consistently improves the accuracy of needle placement compared with landmark technique, but whether this improves clinical outcomes is much less consistently demonstrated.
• •In-plane technique allows continuous needle visualisation while the needle remains in the beam; out-of-plane shows only a cross-section, and the bright dot may be the shaft rather than the tip. Neither is universally preferable.
• •Choose a high-frequency linear transducer for superficial targets and a lower-frequency transducer with adequate penetration, commonly curvilinear, for deeper targets such as the hip.
• •Scan before injecting to plan the path and identify vessels and nerves, keep the needle tip in view, and confirm placement by watching the injectate spread into the intended compartment.
• •Guidance is most justified for deep or small targets, structures near nerves or vessels, difficult access, unreliable landmarks, diagnostic blocks and after a failed landmark injection.
• •Remember the pitfalls: operator dependence, anisotropy mimicking a tear, poor needle visualisation at steep angles, and the need for sterile gel, a probe cover and transducer decontamination.